INTRA-CELLULAR THERAPIES INC

CUSIP: 46116X101 Class: Common Stock

Nicholas Investment Partners, LP's Holding History (CIK: 0001389574)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 176,870 Value ($000) $14,772 Avg Close — Range —
Q3 2024
Shares 154,798 Value ($000) $11,327 Avg Close — Range —
Q2 2024
Shares 151,409 Value ($000) $10,370 Avg Close — Range —
Q1 2024
Shares 71,371 Value ($000) $4,939 Avg Close — Range —
Q4 2023
Shares 50,244 Value ($000) $3,598 Avg Close — Range —
Q3 2023
Shares 335,554 Value ($000) $17,479 Avg Close — Range —
Q2 2023
Shares 499,503 Value ($000) $31,629 Avg Close — Range —
Q4 2022
Shares 413,507 Value ($000) $21,883 Avg Close — Range —
Q3 2022
Shares 390,678 Value ($000) $18,178 Avg Close — Range —
Q2 2022
Shares 433,959 Value ($000) $24,770 Avg Close — Range —
Q1 2022
Shares 562,373 Value ($000) $34,412 Avg Close — Range —
Q4 2021
Shares 652,886 Value ($000) $34,172 Avg Close — Range —
Q3 2021
Shares 613,212 Value ($000) $22,861 Avg Close — Range —
Q2 2021
Shares 598,261 Value ($000) $24,421 Avg Close — Range —
Q1 2021
Shares 554,545 Value ($000) $18,816 Avg Close — Range —
Q4 2020
Shares 390,289 Value ($000) $12,411 Avg Close — Range —
Q3 2020
Shares 457,720 Value ($000) $11,745 Avg Close — Range —
Q3 2016
Shares 43,181 Value ($000) $658 Avg Close — Range —
Q2 2016
Shares 46,400 Value ($000) $1,801 Avg Close — Range —
Q2 2015
Shares 8,130 Value ($000) $260 Avg Close — Range —